A DETAILED PROFILE OF THE END-OF-LIFE CARE IN MEDICARE

医疗保险中临终关怀的详细概况

基本信息

  • 批准号:
    6083371
  • 负责人:
  • 金额:
    $ 44.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-30 至 2000-09-29
  • 项目状态:
    已结题

项目摘要

The objectives of this proposed study are: 1. To document in detail the cost and patterns of end-of-life care for Medicare beneficiaries within five broad categories (cancers, dementia, congestive heart failure, chronic obstructive pulmonary disease, all other deaths). 2. To examine the geographic variations in cost and patterns of care within these categories, and determine the factors associated with variation in cost and patterns of care for these diseases. 3. To demonstrate methods for prospectively identifying cohorts of beneficiaries likely to be nearing end of life, and to calculate prospective capitation rates for these cohorts. The overall goal of this work is to obtain basic research needed to reshape Medicare payment policy for end-of-life care. Medicare's fractured fee-for-service payment discourages integrated management of end stage disease and encourages acute over palliative treatment. Integrated payment approaches (per diem, capitation, or other) have greater potential to encourage delivery of appropriate and compassionate end-of-life care. Restructuring Medicare policy toward more integrated payment requires identifying individuals likely to benefit from special end-of-life care, determining services and providers to be covered under an integrated payment, calculating Medicare's average cost for those services, and analyzing variation around that average cost. The proposed research will provide detailed data needed to discuss options for restructuring Medicare payment for end-of-life care. We propose a combination of descriptive analysis and hypothesis testing. First, because so little detailed information is available, we propose to create a databook on Medicare end-of- life care, a comprehensive profile of cost and use. Descriptive analyses will be guided by a National Advisory Board of experts in end-of-life care, with a goal of developing a useful reference on Medicare-financed end-of-life care. Second, we will test specific hypotheses regarding cost and use.
本研究的目的是:1。详细记录五大类(癌症、痴呆、充血性心力衰竭、慢性阻塞性肺病、所有其他死亡)医疗保险受益人的临终关怀费用和模式。2. 检查这些类别中成本和护理模式的地理差异,并确定与这些疾病的成本和护理模式差异相关的因素。3. 演示前瞻性识别可能接近生命终点的受益人队列的方法,并计算这些队列的预期资本化率。这项工作的总体目标是获得重塑临终关怀医疗保险支付政策所需的基础研究。医疗保险支离破碎的按服务收费的支付方式阻碍了对终末期疾病的综合管理,并鼓励急性而非姑息性治疗。综合支付方式(按日支付、按人头支付或其他方式)更有可能鼓励提供适当和富有同情心的临终关怀。调整医疗保险政策,使其朝着更综合的支付方式发展,需要确定可能受益于特殊临终关怀的个人,确定综合支付所涵盖的服务和提供者,计算这些服务的医疗保险平均成本,并分析平均成本的变化。拟议的研究将提供详细的数据,以讨论重组医疗保险支付临终关怀的选择。我们建议将描述性分析和假设检验相结合。首先,由于可获得的详细信息太少,我们建议创建一个关于医疗保险临终关怀的数据手册,一个全面的成本和使用概况。描述性分析将由国家临终关怀专家咨询委员会指导,其目标是为医疗保险资助的临终关怀提供有用的参考。其次,我们将测试有关成本和使用的具体假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DORCAS JOANNE LYNN其他文献

DORCAS JOANNE LYNN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DORCAS JOANNE LYNN', 18)}}的其他基金

CLINICAL TRIAL: REBIF (IFN BETA-1A) AND BETASERON (IFN BETA-1B) IN IFN-NAIVE MS
临床试验:REBIF (IFN BETA-1A) 和 BETASERON (IFN BETA-1B) 在 IFN-NAIVE MS 中的应用
  • 批准号:
    7718678
  • 财政年份:
    2007
  • 资助金额:
    $ 44.56万
  • 项目类别:
Improving Influeza Immunization In Long Term Care Staff
改善长期护理人员的流感免疫接种
  • 批准号:
    7105670
  • 财政年份:
    2004
  • 资助金额:
    $ 44.56万
  • 项目类别:
Improving Influeza Immunization In Long Term Care Staff
改善长期护理人员的流感免疫接种
  • 批准号:
    6903350
  • 财政年份:
    2004
  • 资助金额:
    $ 44.56万
  • 项目类别:
IMPROVEMENTS & INNOVATIONS IN END OF LIFE CARE
改进
  • 批准号:
    6401056
  • 财政年份:
    2001
  • 资助金额:
    $ 44.56万
  • 项目类别:
Center for Patient Safety at the End of Life
临终患者安全中心
  • 批准号:
    6528293
  • 财政年份:
    2001
  • 资助金额:
    $ 44.56万
  • 项目类别:
EPISTEMOLOGY AND ETHICS OF QUALITY IMPROVEMENT
质量改进的认识论和伦理学
  • 批准号:
    6460206
  • 财政年份:
    2001
  • 资助金额:
    $ 44.56万
  • 项目类别:
Center for Patient Safety at the End of Life
临终患者安全中心
  • 批准号:
    6413935
  • 财政年份:
    2001
  • 资助金额:
    $ 44.56万
  • 项目类别:
Center for Patient Safety at the End of Life
临终患者安全中心
  • 批准号:
    6658033
  • 财政年份:
    2001
  • 资助金额:
    $ 44.56万
  • 项目类别:
A DETAILED PROFILE OF THE END-OF-LIFE CARE IN MEDICARE
医疗保险中临终关怀的详细概况
  • 批准号:
    6337256
  • 财政年份:
    1999
  • 资助金额:
    $ 44.56万
  • 项目类别:
PHASE 2 STUDY OF HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
HU23F2G 在多发性硬化症急性发作中的 2 期研究
  • 批准号:
    6263476
  • 财政年份:
    1998
  • 资助金额:
    $ 44.56万
  • 项目类别:

相似海外基金

ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
  • 批准号:
    493118
  • 财政年份:
    2023
  • 资助金额:
    $ 44.56万
  • 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
  • 批准号:
    487508
  • 财政年份:
    2023
  • 资助金额:
    $ 44.56万
  • 项目类别:
    Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
  • 批准号:
    10633608
  • 财政年份:
    2023
  • 资助金额:
    $ 44.56万
  • 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
  • 批准号:
    489950
  • 财政年份:
    2023
  • 资助金额:
    $ 44.56万
  • 项目类别:
    Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
  • 批准号:
    23K15702
  • 财政年份:
    2023
  • 资助金额:
    $ 44.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
  • 批准号:
    10700228
  • 财政年份:
    2023
  • 资助金额:
    $ 44.56万
  • 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
  • 批准号:
    10543560
  • 财政年份:
    2022
  • 资助金额:
    $ 44.56万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测
  • 批准号:
    10445739
  • 财政年份:
    2022
  • 资助金额:
    $ 44.56万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
  • 批准号:
    10772527
  • 财政年份:
    2022
  • 资助金额:
    $ 44.56万
  • 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
  • 批准号:
    10449417
  • 财政年份:
    2022
  • 资助金额:
    $ 44.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了